DUBLIN, Dec. 16, 2020 /PRNewswire/ — The “e-Clinical Trial Technologies – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Amid the COVID-19 crisis, the global market for e-Clinical Trial Technologies estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$9.9 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027. EDC, one of the segments analyzed in the report, is projected to record a 8.8% CAGR and reach US$4.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RTSM segment is readjusted to a revised 8.1% CAGR for the next 7-year period.
The U. S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 8.3% CAGR
The e-Clinical Trial Technologies market in the U. S. is estimated at US$1.6 Billion in the year…